Qian Cao

Director/Board Member en NINGBO MENOVO PHARMACEUTICAL CO., LTD. .

Fortuna: 499 200 $ al 30/04/2024

42 años

Health Technology

Perfil

Qian Cao has worked as a Director at Zhejiang Liaoyuan Pharmaceutical Co., Ltd.
since 2015 and at Ningbo Menovo Pharmaceutical Co., Ltd.
since 2018.

Participaciones conocidas en empresas públicas

Empresa	Fecha	Número de acciones	Valoración	Fecha de valoración
NINGBO MENOVO PHARMACEUTICAL CO., LTD. CLASS A 0.09%	19/03/2023	192 103 ( 0.09% )	366 087 $	30/04/2024
NINGBO MENOVO PHARMACEUTICAL CO. LTD. 3.11%	19/03/2023	69 851 ( 3.11% )	133 114 $	30/04/2024

Cargos activos de Qian Cao

Empresas	Cargo	Inicio
NINGBO MENOVO PHARMACEUTICAL CO., LTD.	Director/Board Member	20/06/2018
Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.	Director/Board Member	25/04/2015

Todos los cargos activos de Qian Cao

Experiencias
Funciones ocupadas

Activas

Inactivas

Empresas cotizadas

Empresas privadas

Ver el detalle de la experiencia de Qian Cao.

Relaciones

Relaciones de 1er grado

Empresas vinculadas al 1er grado

Hombre

Mujer

Administradores

Ejecutivos

Consultar la red personal

Empresas relacionadas

Empresas cotizadas	1
NINGBO MENOVO PHARMACEUTICAL CO., LTD.	Health Technology

Empresas privadas	1
Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Zhejiang Liaoyuan Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Zhejiang Liaoyuan Pharmaceutical Co., Ltd. engages in the manufacturing of APIs and intermediates for anticoagulants, antidepressants, and cardiovascular drugs. Its products include Clopidogrel, Ticlopidine Hydrochloride, Mirtazapine, 2-thiophene ethanol, 2-thiophene ethylamine, and other related pharmaceutical products. The company was founded on March 26, 1994 and is headquartered in Linhai, China.	Health Technology